November 10, 2020

President Piñera welcomes advances in developing a COVID-19 vaccine

President Piñera welcomes advances in developing a COVID-19 vaccine
Studies by Pfizer and BioNTech show the vaccine to be 90% effective in preventing the disease.

On Monday, the President of Chile, Sebastián Piñera welcomed the announcement that promising advances had been made in one of several efforts to develop a COVID-19 vaccine.  

“One of the companies working on a vaccine, Pfizer, with whom we have a supply agreement, announced today extremely promising results from their Phase III clinical trials,” said the President.

Last week, the President announced that a preliminary agreement with the Pfizer-BioNTech alliance had been reached to supply 10 million doses of an eventual vaccine.

Currently, Chile is working with four candidates to produce the vaccines.

Furthermore, the President has highlighted an agreement with the COVAX global alliance led by the World Health Organization, the European Union and the Bill and Melinda Gates Foundation that would provide access to vaccines.

The President also outlined the vaccination strategy to be used once the doses become available.

The government reiterates its call to maintain COVID-safe measures to prevent the spread of the disease.